Cargando…
FRI593 Ergocalciferol And Pancreatic β-Cell Function In New-onset Type 1 Diabetes: A Randomized Controlled Trial
Disclosure: B.U. Nwosu: None. S. Parajuli: None. R. Sharma: None. B.A. Barton: None. A.F. Lee: None. Background: The impact of high-dose vitamin D (ergocalciferol) on pancreatic β-cell function in youth with newly diagnosed type 1 diabetes (T1D) is unclear. Objective: To determine the effect of ergo...
Autores principales: | Nwosu, Benjamin Udoka, Parajuli, Sadichchha, Sharma, Rohit, Barton, Bruce Alan, Lee, Austin F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553729/ http://dx.doi.org/10.1210/jendso/bvad114.1500 |
Ejemplares similares
-
Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021) -
Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021) -
Prediabetes: Adherence to Nutrition Visits Decreases HbA1c in Children and Adolescents
por: Parajuli, Sadichchha, et al.
Publicado: (2022) -
COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021) -
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)